style="display:block"
data-ad-client="ca-pub-9297790391718957"
data-ad-slot="7959548050"
data-ad-format="auto">





Total Defense Goes Unlimited

pan>)--Total Defense, Inc., the leading provider of solutions to combat the

InVivo Therapeutics CEO Frank Reynolds Scheduled to Appear on KGO-TV in San Francisco

pan>)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of

maxiPago! Selects Kount to Bolster Fraud Protection for Its Multi-Currency Solution

pan>)--maxiPago!, the first gateway/payment services provider built for Latin

Furmanite Corporation Reports First Quarter 2012 Results

pan>)--Furmanite Corporation (NYSE: FRM) today reported results for the quarter

Molina Healthcare Named to 2012 Fortune 500 List

pan>)--Molina Healthcare, Inc. (NYSE:MOH) announced today that it has been

Citrix Startup Accelerator Announces Startup.Synergy $100K Challenge Finalists

pan>)--Citrix Startup Accelerator, the companys corporate incubator focused on

Research and Markets: Bookselling Market Report 2012

pan>)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/8d54s5/bookselling_market)

Research and Markets: Austria - Telecoms, IP Networks, Digital Media and Forecasts

pan>)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/r5zshx/austria_telecoms)

Research and Markets: Permian Basin Unconventional Plays Special Report

pan>)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/fhhhbs/permian_basin_unco)

Virgin Media Inc.: Transaction in Own Shares

pan>)--Virgin Media Inc. (NASDAQ:VMED)(LSE:VMED) today announced the repurchase

Research and Markets: The Future of the Fragrances Market in the US, to 2016

pan>)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/bzvrw2/the_future_of_the)

GTx Announces Removal of Full Clinical Hold By FDA for Capesaris In Advanced Prostate Cancer

pan>)--GTx, Inc. (Nasdaq: GTXI) announced today that the Food and Drug

ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences

pan>)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops

Syndicate content

style="display:block"
data-ad-client="ca-pub-9297790391718957"
data-ad-slot="7959548050"
data-ad-format="auto">